Intelligence Ventures is a pre-seed and seed venture capital firm investing in AI-powered healthcare startups in the US and Canada. The thesis is simple: in AI healthcare, the data is the product. We back founders who own or generate proprietary datasets that compound into a durable moat.

Pre-seed and seed. Initial checks are $25K–$50K at post-money valuations under $20M, targeting roughly 1% ownership at entry. We reserve capital for pro-rata in top-quartile performers.

Four verticals, four opinions: biotech and pharma tools (deepest moats), medical devices (the hardware-AI frontier), diagnostics (most underbuilt), and healthcare software (most crowded — we're highly selective and only back teams with proprietary data loops, not workflow wrappers).

The United States and Canada. Companies must be operational at the time of investment.

Four filters, no exceptions. Proprietary data — the team owns or generates data no one else can access. Sound science — the underlying biology or technology holds up to expert scrutiny. A multi-disciplinary team of operators, scientists, and builders together from day one. And a credible path to a category-defining outcome, not a nice-to-have feature.

No. We don't back therapeutics directly. We invest in the tools, data, devices, and software that make healthcare AI work — not the drugs themselves.

Apply directly through our application page. We respond fast, give direct feedback, and won't string you along. Expect a decision in days, not weeks.

Scientists in the room on every diligence. Research-first sourcing through a public AI healthcare landscape that pulls founders in. And a small, concentrated fund by design — because the best opportunities at this stage are structurally inaccessible to larger funds.

Intelligence Ventures is a 506(c) emerging-manager fund. Accredited LPs and institutional co-investors interested in specialist AI healthcare exposure can reach us at info@intelligencevc.com.